Lenalidomide
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Lenalidomide
Jul 25, 2024, 00:44 |
Opinion
Manni Mohyuddin: The results of the GEM-CESAR trial are a stunning verdict against early intervention in SMM
Manni Mohyuddin shared on X: "The GEM-CESAR trial of a super aggressive approach to SMM…
Jul 23, 2024, 13:25 |
Insight
Myeloma Paper of the Day, July 23rd, suggested by Robert Orlowski
Robert Orlowski shared on X: “Myeloma Paper of the Day: KRd induction, ASCT, KRd consolidation, & Rd…
Jul 19, 2024, 17:05 |
Insight
Myeloma Paper of the Day, July 19th, suggested by Robert Orlowski
Robert Orlowski shared on X: “Myeloma Paper of the Day: Once-weekly KRd56 appears similar to twice-weekly…
Jul 4, 2024, 14:21 |
Insight
A critical appraisal of the long-term follow-up of CASSIOPEIA trial by Manni Mohyuddin
Manni Mohyuddin shared a post on X: "A critical appraisal of the long-term follow-up of…
Jul 3, 2024, 06:28 |
Blog
Yelak Biru: Is myeloma science and clinical progress fast or slow?
Yelak Biru, President and CEO at the International Myeloma Foundation, shared on X: "Is myeloma…
Jun 5, 2024, 14:51 |
Blog
Diko Kazandjian: IsaVRD more is better
Dickran (Diko) Kazandjian, Professor of Medicine at the Sylvester Comprehensive Cancer Center and Board Member…
Jun 4, 2024, 14:44 |
Insight
Myeloma Paper of the Day, June 4th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Phase III BENEFIT trial shows…
Jun 1, 2024, 02:42 |
Insight
Myeloma Paper of the Day, May 31st, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Phase II trial of Dara-KRd…
May 20, 2024, 14:02 |
Blog
Talha Badar: Rx of Lower risk MDS, non del 5q, failing ESA/luspatercept
Talha Badar, Assistant Professor at Mayo Clinic Comprehensive Cancer Center shared a thread on X:…
Apr 20, 2024, 05:56 |
Insight
Myeloma Paper of the Day suggested by Robert Orlowski, April 18th
Robert Orlowski, Director of the Myeloma Section at MD Anderson Cancer Center, shared on X:…
Mar 3, 2024, 06:41 |
Blog
Amol Akhade: How price per pill of lenalidomide kept on rising in USA
Amol Akhade, Consultant medical oncologist at Suyog Cancer Clinics, shared on X/Twitter: "How price per pill…
Dec 3, 2023, 15:55 |
Stories
Vincent Rajkumar: How a patient with cancer came up with the idea for a randomized trial, and how listening to him saved a lot of lives
Vincent Rajkumar, Editor-in-Chief of the Blood Cancer Journal, shared on Twitter: "I would like to…
Nov 23, 2023, 15:49 |
Blog
List of top 10 plasma cell dyscrasia ASH23 abstracts by Manni Mohyuddin
Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute at the University of Utah, shared…
Oct 19, 2023, 18:07 |
Blog
Vincent Rajkumar: The United States can save 5 to 10 billion a year on lenalidomide if it did what other countries do
Vincent Rajkumar, Professor of Medicine at the Mayo Clinic, shared a thread on X/Twitter: "The…
Oct 18, 2023, 16:36 |
Drugs
Eric Feigl-Ding: Corrupt “SUE TO DELAY” big pharma shenanigan
Eric Feigl-Ding, Faculty, Chair of Public Health, Chief of COVID Task Force at New England…
Oct 17, 2023, 18:11 |
Blog
Vincent Rajkumar: Lenalidomide 1 pill: $10 in Canada / $800 in USA
Vincent Rajkumar, Editor-in-Chief at Blood Cancer Journal, recently shared a post by Russell Sterrett on…
Sep 13, 2023, 15:27 |
Insight
Sophie Castell: DRD is a game changer and will make a tremendous difference to patients’ quality of life.
Sophie Castell, CEO of Myeloma UK, shared Myeloma UK's post on X/Twitter: "DRD is a…
Sep 5, 2023, 17:53 |
Insight
Ola Landgren: In this tweetorial, we delve into a groundbreaking study on multiple myeloma and the immune microenvironment.
Ola Landgren, Professor of Medicine, Chief of the Myeloma Division, and Leader of the Experimental…
Jul 16, 2023, 14:35 |
Drugs
Lenalidomide (Revlimid) used to cost $324/pill back in 2009, Now is $1,000/pill - Michael Lam
Lenalidomide (Revlimid) used to cost $324/pill back in 2009. Now is $1,000/pill. Gradually increase the…
All:
19
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube